Viewing Study NCT05521204


Ignite Creation Date: 2025-12-24 @ 9:15 PM
Ignite Modification Date: 2026-02-27 @ 12:48 AM
Study NCT ID: NCT05521204
Status: RECRUITING
Last Update Posted: 2022-08-30
First Post: 2022-08-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Olverembatinib for FGFR1-rearranged Neoplasms
Sponsor: The First Affiliated Hospital of Soochow University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module